CRD-1835439

N/A

Report date: 2024/07/17 09:41:09
NME

Base Information

Drug NameCRD-1835439
Drug Alias NameCRD-1835439CTX-439
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 12 inhibitorsCyclin-dependent kinase 13 inhibitorsPoly (ADP-Ribose) polymerase degraders
TargetsCyclin-dependent kinase 12Cyclin-dependent kinase 13Poly (ADP-Ribose) polymerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChordia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesChordia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A